ConductScience.org, home

Paper21084697

Oxidized low-density lipoprotein and atherosclerosis.

Steinberg D and 1 other. Arterioscler Thromb Vasc Biol, 2010. Cited by 361 papers, by iCite.

Cite this record

ConductScience Library. Oxidized low-density lipoprotein and atherosclerosis. Papers, record 21084697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21084697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oxidized low-density lipoprotein and atherosclerosis.
PubMed
Journal
Arterioscler Thromb Vasc Biol
PubMed
Year
2010
PubMed
Publication types
Historical Article, Journal Article
PubMed
Citations, by iCite
361
iCite
Relative citation ratio, by iCite
9.37
iCite
Revised in PubMed
2022-03-31
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Steinberg DDaniel
2Witztum JLJoseph L

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtherosclerosisMajor topic
Biomedical ResearchMajor topic
Endothelial CellsMajor topic
Lipoproteins, LDLMajor topic
Animals
History, 20th Century
Humans
Immunity, Innate
Narration
Norway
Oxidation-Reduction
Receptors, Scavenger
United States

Source PubMed

Download CSV of topics

Cited by220

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 361 citations.

PMIDTitleJournalYearIn PapersSource
42798462Factors associated with sarcopenia in elderly patients with type 2 diabetes mellitus.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42798462PubMed
42798332Effectiveness and safety of Breviscapine in the treatment of coronary heart disease: a meta-analysis of randomized controlled trials.Front Cardiovasc Med2026https://conductscience.org/library/papers/42798332PubMed
42737545Interferon Regulatory Factors as Potential Therapeutic Targets in Cardiovascular Disease: Focusing on Vascular Inflammation.Int J Mol Sci2026https://conductscience.org/library/papers/42737545PubMed
42524664Therapeutic potential of hydrogen-rich water (HRW) in oxidative stress-related diseases.J Clin Biochem Nutr2026https://conductscience.org/library/papers/42524664PubMed
42437951Anti-inflammatory agents in atherosclerosis-and a need for reform: Extraordinary claims require extraordinary evidence.J Intern Med2026https://conductscience.org/library/papers/42437951PubMed
42282966OxLDL-induced ferroptosis and pyroptosis in atherosclerosis: a mini review.Front Immunol2026https://conductscience.org/library/papers/42282966PubMed
42183881Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials.Eur Heart J2026https://conductscience.org/library/papers/42183881PubMed
42110962Lipoprotein(a): A Novel Risk Factor for Heart Failure and Biomarker of Prognosis? From Pathophysiology to Clinical Practice.Card Fail Rev2026https://conductscience.org/library/papers/42110962PubMed
42042621Biomarkers of Remote Ischaemic Conditioning in Stroke and Cerebral Small Vessel Disease: A Narrative Review.NeuroSci2026https://conductscience.org/library/papers/42042621PubMed
41745332Atherosclerosis: A Pathologist's Perspective.J Cardiovasc Dev Dis2026https://conductscience.org/library/papers/41745332PubMed
41437771An updated overview of lipid-regulated immunobiology in macrophages.Acta Biochim Biophys Sin (Shanghai)2026https://conductscience.org/library/papers/41437771PubMed
41322488Value of lipoprotein(a) in predicting severity of coronary artery stenosis in patients with chronic coronary artery disease: a cross-sectional study in Vietnam.Front Cardiovasc Med2025https://conductscience.org/library/papers/41322488PubMed
40833492Anti-Atherogenic Mechanisms and Therapies.Curr Atheroscler Rep2025https://conductscience.org/library/papers/40833492PubMed
40821628PCSK9 inhibitors reduces arterial stiffness in patients with acute coronary syndrome.J Med Biochem2025https://conductscience.org/library/papers/40821628PubMed
40681803Coronary plaque healing: a safety net or a hazard indicator?J Thromb Thrombolysis2026https://conductscience.org/library/papers/40681803PubMed
40577270Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy.PLoS One2025https://conductscience.org/library/papers/40577270PubMed
40552286Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins.Front Immunol2025https://conductscience.org/library/papers/40552286PubMed
40427454The Dark Triad of Particulate Matter, Oxidative Stress and Coronary Artery Disease: What About the Antioxidant Therapeutic Potential.Antioxidants (Basel)2025https://conductscience.org/library/papers/40427454PubMed
40425644The influence of habitual tooth brushing frequency on individuals diagnosed with coronary artery disease.Sci Rep2025https://conductscience.org/library/papers/40425644PubMed
40404619The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40404619PubMed

See all 220 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21084697

GET https://conductscience.org/api/papers/v1/21084697/cited_by?page=2